Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057967
Status:
COMPLETED
Last Update Posted:
2019-02-06
First Post:
2003-04-07
Brief Title:
Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
Sponsor:
Northwestern University
Organization:
Northwestern University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent mycosis fungoidesSezary syndrome | View |
| stage I mycosis fungoidesSezary syndrome | View |
| stage II mycosis fungoidesSezary syndrome | View |
| stage III mycosis fungoidesSezary syndrome | View |
| stage IV mycosis fungoidesSezary syndrome | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| stage I cutaneous T-cell non-Hodgkin lymphoma | View |
| stage II cutaneous T-cell non-Hodgkin lymphoma | View |
| stage III cutaneous T-cell non-Hodgkin lymphoma | View |
| stage IV cutaneous T-cell non-Hodgkin lymphoma | View |